PofoliaShared via Pofolia

eLife· 2026Q1

A GCN1-independent activator of the kinase GCN2

Jiayi Zhu, Giulia Emanuelli, Glenn Robert Masson, Vanesa Vinciauskaite et al.

Short summary

A novel GCN2 activator, identified via in cellulo screening, stimulates the kinase independently of GCN1 and binds the ATP pocket without protruding into allosteric sites.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Identified three novel GCN2 activators through an in cellulo chemical screen.
  • One identified activator stimulates GCN2 independently of GCN1.
  • This activator binds to the ATP pocket of GCN2 without protruding into adjacent pockets.
  • The binding mode differs from existing ATP-pocket binding inhibitors.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Mutations of EIF2AK4 , which encodes the eIF2α kinase GCN2, cause a severe inherited form of pulmonary hypertension called pulmonary veno-occlusive disease (PVOD). Some pathogenic variants of GCN2 are amenable to pharmacological reactivation by low concentrations of ATP-pocket binding inhibitors. Kinase inhibition at modestly elevated concentrations limits the clinical utility of these drugs against PVOD. We therefore performed an in cellulo chemical screen for GCN2 activators and identified three structurally distinct compounds with low micromolar stimulatory activities. Unlike previously described GCN2 activators, one of these molecules activated GCN2 independently of GCN1. Modelling supported by structure activity screens suggested it binds within the ATP-pocket of GCN2, but unlike existing ligands does not protrude inward into the allosteric pocket or outward into the solvent. This overcomes a key requirement of other GCN2 activators.

The authors' abstract, as published at the source. eLife, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Pulmonary and Respiratory Medicine

Pulmonary and Respiratory MedicineMedicine